Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Investigator-initiated Direct Comparative Real-world Study of Acute Hereditary Angioedema Therapies

Next Previous
Trial Profile

Investigator-initiated Direct Comparative Real-world Study of Acute Hereditary Angioedema Therapies

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Dec 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 23 Dec 2018 New trial record
  • 06 Dec 2018 According to a Pharming Group NV media release, further data regarding reasons for drug selection and subjective observations on the performance of the drugs in each attack are being analysed and the full results of the study will be published by the investigators in due course.
  • 06 Dec 2018 According to a Pharming Group NV media release, this study was led by Professor Dr Marcus Magerl of the Department of Dermatology and Allergy at the Charite Universitatsmedizin Berlin, Berlin, Germany.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top